• HOME

  • WHAT I DO

    • Writer and Consultant
    • Speaker and Moderator
    • Media Trainer
  • BOOKS

  • ABOUT ME

  • CONTACT

  • More

    Use tab to navigate through the menu items.
    • All Journalism
    • Investment
    • Interviews
    • Columns
    • Article
    Search
    • Jun 9, 2019
    • 1 min

    (Telegraph: Questor) Reckitt Benckiser once exuded vim and vigour but now looks a little peaky

    Healthcare giant Reckitt Benckiser still cannot shake off sluggish growth despite carving itself into two divisions.
    • Jun 2, 2019
    • 1 min

    (Telegraph: Questor) Collapse of Jamie’s Italian shows how tough it will be for Restaurant Group

    The collapse of Jamie Oliver’s restaurant empire is a reminder that investors tempted to put money into high street food might be better...
    • May 26, 2019
    • 1 min

    (Telegraph: Questor) Bunzl’s halo has slipped and the shares have plunged. Time to buy

    Until recently Bunzl was a pin-up of the support services sector, but a hiccup in the US has sent investors running for cover.
    • May 19, 2019
    • 1 min

    (Telegraph:Questor) As Uber Eats prepares to gobble up market share it’s time to lose Just Eat

    The American giant Uber Eats' readiness to sacrifice profits for scale is yet another challenge for its British rival Just Eat
    • May 12, 2019
    • 1 min

    (Telegraph: Questor) Coca-Cola Hellenic looks like the real thing - but the shares aren’t cheap

    Questor share tip: the Coke bottling company is growing nicely and has valuable exposure to emerging markets.
    • May 5, 2019
    • 1 min

    (Telegraph: Questor) Questor: Learning Technologies looks cheap for a tech stock

    Questor share tip: the ‘e-learning’ company has made some canny-looking acquisitions and is expected to grow at a good clip
    • Apr 28, 2019
    • 1 min

    (Telegraph: Questor) It is clear that there is momentum behind Man Group. The shares are a buy

    Questor share tip: the hedge fund manager is better protected from the rise of passive investing than most rivals
    • Apr 14, 2019
    • 1 min

    (Telegraph: Questor) It may not be as highly valued as WeWork but IWG is still best avoided

    https://www.telegraph.co.uk/investing/shares/questor-may-not-highly-valued-wework-iwg-still-best-avoided/
    • Apr 14, 2019
    • 1 min

    (Telegraph) Turnarounds need to be treated with suspicion

    https://www.telegraph.co.uk/business/2019/04/14/turnarounds-need-treated-suspicion/
    • Apr 7, 2019
    • 1 min

    (Telegraph: Questor) Have faith in the Pru and you could get demerged M&GPrudential for nothing

    https://www.telegraph.co.uk/investing/shares/questor-take-leap-faith-pru-could-get-demerged-mgprudential/
    • Mar 31, 2019
    • 1 min

    (Telegraph: Questor) Readers who followed our Britvic tip made fizzy profits, so bank some gain now

    https://www.telegraph.co.uk/investing/shares/questor-readers-followed-britvic-tip-have-made-fizzy-profits/
    • Mar 24, 2019
    • 1 min

    (Telegraph: Questor) Countries won't scrimp on fighting terror, so QinetiQ’s future looks bright

    https://www.telegraph.co.uk/investing/shares/questor-countries-unlikely-scrimp-fighting-terror-qinetiqs-future/
    • Mar 17, 2019
    • 1 min

    (Telegraph: Questor) As oil recovers, IMI is worth buying in anticipation of better times ahead

    https://www.telegraph.co.uk/investing/shares/questor-oil-recovers-imi-worth-buying-anticipation-better-times/
    • Mar 10, 2019
    • 1 min

    (Telegraph: Questor) ConvaTec has lost its momentum so we must stomach our loss and sell

    https://www.telegraph.co.uk/investing/shares/questor-convatec-has-lost-momentum-must-stomach-loss-sell/
    • Mar 3, 2019
    • 1 min

    (Telegraph: Questor) A dizzying series of deals makes media group Ascential one to buy

    https://www.telegraph.co.uk/investing/shares/questor-dizzying-series-deals-makes-ascential-one-buy/
    • Feb 24, 2019
    • 1 min

    (Telegraph: Questor) Hikma, the British drugs firm that makes hay from routine US drugs shortages

    https://www.telegraph.co.uk/investing/shares/questor-british-drugs-firm-makes-hay-americas-routine-drugs/
    • Feb 17, 2019
    • 1 min

    (Telegraph: Questor) A punt on Paddy Power could net big winnings – but a lot could go wrong too

    https://www.telegraph.co.uk/investing/shares/questor-punt-paddy-power-could-net-big-winnings-lot-could/
    • Feb 10, 2019
    • 1 min

    (Telegraph: Questor) Rat-catcher Rentokil is on a roll - but are the shares too expensive?

    https://www.telegraph.co.uk/investing/shares/questor-focused-rat-catcher-rentokil-roll-shares-expensive/
    • Feb 3, 2019
    • 1 min

    (Telegraph: Questor) Investors should plug into Johnson Matthey’s futuristic batteries now

    https://www.telegraph.co.uk/investing/shares/questor-far-sighted-investors-should-plug-johnson-mattheys-futuristic/
    • Jan 27, 2019
    • 1 min

    (Telegraph: Questor) Synthomer’s bosses may not have managed Ineos-style growth but it's a buy

    https://www.telegraph.co.uk/investing/shares/questor-synthomers-bosses-may-not-have-managed-ineos-style-growth/
    12
    3
    45

    Contact Me

    The best way to get in touch with me is via email at james@jamesashton.co

     

    Alternatively you can send me a message via my social media channels on Twitter or LinkedIn

    © 2022 James Ashton - Created by SLAP GROUP

    • LinkedIn - White Circle
    • Twitter - White Circle